Bicycle Therapeutics plc (BCYC)
USD 6.83
(-8.14%)
USD 6.83
(-8.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -481.46 Million USD | -63.3% |
| 2022 | -294.82 Million USD | 25.24% |
| 2021 | -394.34 Million USD | -228.03% |
| 2020 | -120.21 Million USD | -33.24% |
| 2019 | -90.22 Million USD | -42.36% |
| 2018 | -63.38 Million USD | 6.33% |
| 2017 | -67.66 Million USD | -619.67% |
| 2016 | -9.4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -885.32 Million USD | 4.23% |
| 2024 Q1 | -413.17 Million USD | 14.18% |
| 2024 Q2 | -918.62 Million USD | -122.33% |
| 2023 Q3 | -526.39 Million USD | -79.44% |
| 2023 Q2 | -293.35 Million USD | -20.06% |
| 2023 Q1 | -244.34 Million USD | 17.12% |
| 2023 Q4 | -481.46 Million USD | 8.54% |
| 2023 FY | -481.46 Million USD | -63.3% |
| 2022 Q4 | -294.82 Million USD | 7.12% |
| 2022 Q3 | -317.42 Million USD | 2.99% |
| 2022 Q2 | -327.22 Million USD | 9.17% |
| 2022 Q1 | -360.27 Million USD | 8.64% |
| 2022 FY | -294.82 Million USD | 25.24% |
| 2021 Q1 | -162.67 Million USD | -35.32% |
| 2021 FY | -394.34 Million USD | -228.03% |
| 2021 Q4 | -394.34 Million USD | -74.14% |
| 2021 Q3 | -226.45 Million USD | -36.8% |
| 2021 Q2 | -165.53 Million USD | -1.76% |
| 2020 FY | -120.21 Million USD | -33.24% |
| 2020 Q4 | -120.21 Million USD | 10.34% |
| 2020 Q3 | -134.08 Million USD | -40.54% |
| 2020 Q2 | -95.4 Million USD | 11.62% |
| 2020 Q1 | -107.94 Million USD | -19.64% |
| 2019 Q2 | -106.31 Million USD | -86.68% |
| 2019 Q4 | -90.22 Million USD | 3.95% |
| 2019 Q3 | -93.93 Million USD | 11.64% |
| 2019 FY | -90.22 Million USD | -42.36% |
| 2019 Q1 | -56.95 Million USD | 10.15% |
| 2018 Q3 | -47.92 Million USD | 0.0% |
| 2018 FY | -63.38 Million USD | 6.33% |
| 2018 Q1 | 67.66 Million USD | 200.0% |
| 2018 Q4 | -63.38 Million USD | -32.26% |
| 2017 Q4 | -67.66 Million USD | 0.0% |
| 2017 FY | -67.66 Million USD | -619.67% |
| 2016 FY | -9.4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -760.685% |
| Alkermes plc | -166.73 Million USD | -188.755% |
| Agenus Inc. | 274.13 Million USD | 275.631% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 125.748% |
| Aptorum Group Limited | 1.35 Million USD | 35579.048% |
| Ardelyx, Inc. | 34.51 Million USD | 1495.071% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 11349.229% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1431.38% |
| ChromaDex Corporation | -24.04 Million USD | -1902.108% |
| Chimerix, Inc. | -25.51 Million USD | -1786.848% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 7009.612% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1933.48% |
| CRISPR Therapeutics AG | -150.84 Million USD | -219.18% |
| Precision BioSciences, Inc. | -85.41 Million USD | -463.713% |
| Dyadic International, Inc. | -6.37 Million USD | -7448.754% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2921.823% |
| Fortress Biotech, Inc. | 7.66 Million USD | 6381.37% |
| Lantern Pharma Inc. | -21.7 Million USD | -2118.407% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -335.571% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -5535.691% |
| Incyte Corporation | -3.17 Billion USD | 84.836% |
| IO Biotech, Inc. | -140.69 Million USD | -242.196% |
| Jaguar Health, Inc. | 29.39 Million USD | 1738.144% |
| Novavax, Inc. | -298.29 Million USD | -61.407% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 9121.304% |
| Opthea Limited | 28.15 Million USD | 1809.91% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -2767.753% |
| ContextLogic Inc. | -232 Million USD | -107.529% |
| MiMedx Group, Inc. | -33.9 Million USD | -1320.215% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 4822.58% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -20679.516% |
| NextCure, Inc. | -6.47 Million USD | -7333.488% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -853.381% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -7447.688% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 4058.369% |
| Vaxcyte, Inc. | -368.22 Million USD | -30.753% |
| PDS Biotechnology Corporation | -32.7 Million USD | -1371.976% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2886.59% |
| Pharming Group N.V. | 109.8 Million USD | 538.479% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -2667.688% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -174.763% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -2499.734% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -2499.734% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -6681.225% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -8116.16% |
| Acelyrin, Inc. | -216.9 Million USD | -121.973% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -8481.891% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -27827.32% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1488.553% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -6977.275% |
| Senti Biosciences, Inc. | 1.74 Million USD | 27770.517% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -160.806% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -521.641% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -7842.379% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 482681.764% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 76766.72% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -311.349% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -186.191% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 534.263% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -6238.428% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -272.901% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 7083.25% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -98.655% |
| Immix Biopharma, Inc. | -17.5 Million USD | -2649.702% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -52.025% |
| MEI Pharma, Inc. | -3.7 Million USD | -12895.061% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 3948.349% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 397.676% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1832.332% |
| Fortress Biotech, Inc. | 7.66 Million USD | 6381.37% |
| Precigen, Inc. | -481 Thousand USD | -99997.089% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 3519.267% |
| AlloVir, Inc. | -62.69 Million USD | -667.988% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -765.73% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 880.766% |
| ImmuCell Corporation | 10.99 Million USD | 4480.731% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -212.345% |
| Onconetix, Inc. | 5.33 Million USD | 9130.717% |
| PureTech Health plc | -167.19 Million USD | -187.964% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1480.653% |
| Elevation Oncology, Inc. | -19.11 Million USD | -2418.396% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -9707.843% |
| Seer, Inc. | -4.24 Million USD | -11255.354% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1903.025% |
| Innoviva, Inc. | 255.56 Million USD | 288.395% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -761.856% |
| ESSA Pharma Inc. | -33.62 Million USD | -1332.018% |
| GlycoMimetics, Inc. | -40.98 Million USD | -1074.756% |
| GT Biopharma, Inc. | -1.02 Million USD | -47056.415% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -610.306% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 885.979% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -259.092% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -3374.791% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1567.591% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -639009.831% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1460.064% |
| Aptose Biosciences Inc. | -8.19 Million USD | -5775.234% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -15287.16% |
| Soligenix, Inc. | -4.95 Million USD | -9623.469% |
| Century Therapeutics, Inc. | 847 Thousand USD | 56943.802% |
| Kura Oncology, Inc. | -20.11 Million USD | -2293.215% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -1076.433% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -5633.115% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 26529.616% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -14959.962% |
| Autolus Therapeutics plc | -186.59 Million USD | -158.022% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -876.527% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -74.575% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1505.005% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 392.92% |
| GRI Bio, Inc. | -1.79 Million USD | -26737.625% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -5259.73% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -1347.716% |
| IGM Biosciences, Inc. | -72.6 Million USD | -563.123% |
| INmune Bio, Inc. | -25.41 Million USD | -1794.719% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 418.956% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -850.407% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2862.988% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -16589.059% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1366.518% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -1069.035% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1610.011% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 227.389% |
| Verastem, Inc. | -37.27 Million USD | -1191.558% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -5206.591% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -828.362% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -3081.15% |
| Histogen Inc. | -7.48 Million USD | -6330.707% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -2128.31% |
| Surrozen, Inc. | -32.66 Million USD | -1373.999% |
| Organovo Holdings, Inc. | -1.5 Million USD | -31848.706% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -11353.988% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 2639.355% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 18504.702% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 11684.865% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -5644.641% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -1008.298% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -3202.954% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -51.983% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -66579.639% |
| Apollomics, Inc. | -27.39 Million USD | -1657.5% |
| Amarin Corporation plc | -191.04 Million USD | -152.024% |
| Mesoblast Limited | 55.96 Million USD | 960.331% |
| Turnstone Biologics Corp. | -14.58 Million USD | -3201.337% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1803.634% |
| Synaptogenix, Inc. | -28.66 Million USD | -1579.839% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -51338.782% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 1087.989% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -55748.874% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -6526.228% |
| Exelixis, Inc. | -73.05 Million USD | -559.092% |
| Better Therapeutics, Inc. | -860 Thousand USD | -55884.535% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1905.026% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -99.472% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 65510.846% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -6372.953% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 38494.498% |
| Gritstone bio, Inc. | 39.49 Million USD | 1319.212% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -472.487% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -18191.846% |
| Avid Bioservices, Inc. | 169.72 Million USD | 383.67% |
| Insmed Incorporated | 721.62 Million USD | 166.72% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -5166.82% |
| MediWound Ltd. | -5.32 Million USD | -8946.731% |
| OmniAb, Inc. | 9.2 Million USD | 5331.631% |
| Alector, Inc. | -35.63 Million USD | -1251.031% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 660.034% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -9670.028% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 3736.732% |
| Zai Lab Limited | -775 Million USD | 37.875% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 241.377% |
| Aura Biosciences, Inc. | -21.52 Million USD | -2136.78% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -483.738% |
| Immunic, Inc. | -45.34 Million USD | -961.903% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -149.187% |
| Veracyte, Inc. | -203.82 Million USD | -136.217% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 175.43% |
| FibroGen, Inc. | 56.76 Million USD | 948.146% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 5506.704% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -16930.528% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -23155.366% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 110.489% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -14310.865% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -190.103% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2795.482% |
| Galecto, Inc. | -21.21 Million USD | -2169.358% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1924.246% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 130.678% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1867.42% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -4084.123% |
| XBiotech Inc. | -200.02 Million USD | -140.706% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -472.487% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 10733.105% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -1265.36% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -523.517% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 8560.148% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -182.526% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -421.215% |
| Vaxxinity, Inc. | 10.13 Million USD | 4851.944% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 165.393% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -4371.462% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -629.982% |
| NexImmune, Inc. | -3.13 Million USD | -15264.45% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -13844.761% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -3086.107% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1676.631% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -5263.905% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -386387.658% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -1086.698% |
| Ainos, Inc. | 4.07 Million USD | 11906.658% |
| Pluri Inc. | 22.82 Million USD | 2209.015% |
| Prothena Corporation plc | -608.34 Million USD | 20.857% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -305.425% |
| Celularity Inc. | 65.19 Million USD | 838.56% |
| Rallybio Corporation | -24.1 Million USD | -1897.623% |
| Cue Biopharma, Inc. | -33.81 Million USD | -1323.658% |
| MeiraGTx Holdings plc | -40.3 Million USD | -1094.648% |
| Omeros Corporation | 331.17 Million USD | 245.381% |
| Humacyte, Inc. | -22.48 Million USD | -2041.186% |
| Immunocore Holdings plc | -358.59 Million USD | -34.265% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1859.174% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1458.095% |
| Blueprint Medicines Corporation | 702.83 Million USD | 168.503% |
| CalciMedica, Inc. | -5.53 Million USD | -8606.456% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -155.8% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -4613.795% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -1102.555% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -1347.89% |
| Pulmatrix, Inc. | -10.41 Million USD | -4521.935% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -7955.329% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -1162.301% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -332.189% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -703.194% |
| Cytokinetics, Incorporated | 642.37 Million USD | 174.951% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -8168.367% |
| Nutriband Inc. | -251.65 Thousand USD | -191218.739% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -1311.14% |
| Vor Biopharma Inc. | 4.3 Million USD | 11296.907% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 92.023% |
| Evogene Ltd. | -19.63 Million USD | -2352.21% |
| ProKidney Corp. | -56.23 Million USD | -756.154% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -889.207% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -5112.269% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 135.301% |
| CorMedix Inc. | -43.05 Million USD | -1018.325% |
| BioLineRx Ltd. | 7.33 Million USD | 6663.073% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1653.02% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 1143.333% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1585.927% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 21685.328% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -2010.217% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2814.784% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -541.323% |
| MediciNova, Inc. | -50.78 Million USD | -848.077% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -510.96% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -2140228.962% |
| GeoVax Labs, Inc. | -6.45 Million USD | -7361.61% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -140.949% |
| Biomea Fusion, Inc. | -166.57 Million USD | -189.048% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -169.014% |
| Mereo BioPharma Group plc | -51.46 Million USD | -835.45% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -407.641% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -63.899% |
| Absci Corporation | -72.59 Million USD | -563.196% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 10644.612% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -105.372% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -411.052% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -403.121% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -1132.224% |
| Allakos Inc. | -24.97 Million USD | -1827.796% |
| Imunon, Inc. | -4.21 Million USD | -11325.817% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -3165.954% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -255.589% |
| BioAtla, Inc. | -109.01 Million USD | -341.668% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 65510.846% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -51174.441% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 4123.625% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -2170.749% |
| XOMA Corporation | -29 Million USD | -1560.231% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2807.409% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -5240.14% |
| aTyr Pharma, Inc. | -7.44 Million USD | -6363.512% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -286.299% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -131.292% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -488.742% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -419.029% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -55937.706% |
| Akari Therapeutics, Plc | -3.84 Million USD | -12421.899% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 29767.26% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 134.867% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -40422.92% |
| UroGen Pharma Ltd. | 4.39 Million USD | 11064.86% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 524.271% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 669157.28% |
| Orgenesis Inc. | 21.78 Million USD | 2310.186% |
| Entera Bio Ltd. | -10.62 Million USD | -4429.749% |
| GH Research PLC | -78.07 Million USD | -516.657% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -2060.207% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1706.02% |
| Xencor, Inc. | 29.64 Million USD | 1724.163% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -24342.282% |
| Replimune Group, Inc. | 1.41 Million USD | 34198.229% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -196490.965% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -280.856% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -40422.92% |
| Portage Biotech Inc. | -4.98 Million USD | -9566.071% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -2140228.962% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -628.149% |
| OncoCyte Corporation | -6.56 Million USD | -7236.081% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 53750.549% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -10468.585% |
| Purple Biotech Ltd. | -14.13 Million USD | -3305.482% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1926.717% |
| scPharmaceuticals Inc. | -6.54 Million USD | -7256.257% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -2784.389% |
| HilleVax, Inc. | -165.48 Million USD | -190.943% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -18870.331% |
| Tharimmune, Inc. | -10.93 Million USD | -4302.849% |
| Genprex, Inc. | -6.73 Million USD | -7045.941% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -30.547% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -444.277% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -34265.953% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -14415.37% |
| OKYO Pharma Limited | -826.84 Thousand USD | -58129.203% |
| Savara Inc. | 153 Thousand USD | 314784.314% |
| Curis, Inc. | -23.88 Million USD | -1915.603% |
| Daré Bioscience, Inc. | -5.15 Million USD | -9234.535% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -61943.757% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -7655.59% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 40730.127% |
| BeiGene, Ltd. | -2.25 Billion USD | 78.631% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 4002.152% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 20.838% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -159.431% |
| Erasca, Inc. | -37.21 Million USD | -1193.71% |
| bluebird bio, Inc. | 108.57 Million USD | 543.458% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -37284.084% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 227.121% |
| DBV Technologies S.A. | -126.98 Million USD | -279.15% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -37284.084% |
| Moderna, Inc. | -2.9 Billion USD | 83.438% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -4550.956% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -4330.134% |
| Molecular Templates, Inc. | 707 Thousand USD | 68200.0% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1434.752% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 238.908% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -486.711% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -424.874% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1391.903% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -1300.591% |
| MacroGenics, Inc. | -66.98 Million USD | -618.768% |
| RenovoRx, Inc. | -1.17 Million USD | -40945.78% |
| Adicet Bio, Inc. | -138.78 Million USD | -246.911% |
| Prime Medicine, Inc. | -27.94 Million USD | -1623.156% |
| Aditxt, Inc. | 18.12 Million USD | 2756.973% |
| Adagene Inc. | -87.62 Million USD | -449.448% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -11458.644% |
| Quantum-Si incorporated | -118.55 Million USD | -306.106% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1437.223% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -6341.73% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -892.531% |
| SciSparc Ltd. | -2.06 Million USD | -23215.593% |
| Vericel Corporation | 1.27 Million USD | 37802.976% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -3915.002% |
| Minerva Neurosciences, Inc. | 41 Million USD | 1274.188% |
| Generation Bio Co. | 31.44 Million USD | 1630.994% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -174.553% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1456.987% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 512.947% |
| Invivyd, Inc. | -198.47 Million USD | -142.582% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -433.363% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -19980.467% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -580.134% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -6954.462% |
| 2seventy bio, Inc. | 181.71 Million USD | 364.957% |
| ADMA Biologics, Inc. | 90.06 Million USD | 634.571% |
| Clene Inc. | 3.34 Million USD | 14515.18% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -5200.922% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -2138.236% |
| GeoVax Labs, Inc. | -6.45 Million USD | -7361.61% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -39.911% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1751.819% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 370.996% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -11667.301% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 9725.49% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -9142.983% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -269.495% |
| Evaxion Biotech A/S | 5.28 Million USD | 9206.889% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -327.712% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -266.768% |
| Trevena, Inc. | 2.25 Million USD | 21422.719% |
| Surrozen, Inc. | -32.66 Million USD | -1373.999% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -834.706% |
| Cingulate Inc. | 3.08 Million USD | 15718.44% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -16293.156% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 6799.137% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -5081.953% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -506.97% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -266.268% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -356.185% |
| Clearmind Medicine Inc. | -3.94 Million USD | -12111.801% |
| Kronos Bio, Inc. | -36.05 Million USD | -1235.405% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 5217.09% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 33119.552% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -787.399% |
| Statera Biopharma, Inc. | 14.41 Million USD | 3439.716% |
| ImmunityBio, Inc. | 618.22 Million USD | 177.879% |
| Korro Bio, Inc. | -132.94 Million USD | -262.16% |
| Kineta, Inc. | -4.54 Million USD | -10502.665% |
| BioVie Inc. | -17.73 Million USD | -2615.19% |
| Codexis, Inc. | -43.27 Million USD | -1012.678% |
| Celularity Inc. | 65.19 Million USD | 838.56% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -15093.026% |
| Celcuity Inc. | 6.78 Million USD | 7197.61% |
| Virax Biolabs Group Limited | -3.36 Million USD | -14208.321% |
| Cibus, Inc. | -8.07 Million USD | -5860.225% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -11284.89% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 10635.383% |
| IN8bio, Inc. | -16.38 Million USD | -2837.745% |
| Kodiak Sciences Inc. | -103.87 Million USD | -363.506% |
| Annexon, Inc. | -193.75 Million USD | -148.493% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 1337508.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -2651.397% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -13605.295% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 145.668% |
| Eyenovia, Inc. | 1.25 Million USD | 38351.071% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1889.508% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -14746.346% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -1348.152% |
| Arcellx, Inc. | -296.95 Million USD | -62.133% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -2368.302% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -717.778% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -2222.898% |
| Moolec Science SA | 117.61 Thousand USD | 409455.02% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -1153.853% |
| Geron Corporation | 14.76 Million USD | 3361.751% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -1169.758% |
| Royalty Pharma plc | 5.65 Billion USD | 108.509% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -240.449% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -6788.508% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -8877.805% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -242.119% |
| Humacyte, Inc. | -22.48 Million USD | -2041.186% |
| Structure Therapeutics Inc. | -124.33 Million USD | -287.221% |
| 89bio, Inc. | -289.05 Million USD | -66.567% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1807.404% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -26903.197% |
| Genelux Corporation | -6.89 Million USD | -6878.794% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1450.169% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 675.924% |
| Notable Labs, Ltd. | -9.77 Million USD | -4824.99% |
| Liquidia Corporation | -80.17 Million USD | -500.513% |
| Mustang Bio, Inc. | -3.73 Million USD | -12787.232% |
| Immunovant, Inc. | -635.22 Million USD | 24.206% |
| Quantum-Si incorporated | -118.55 Million USD | -306.106% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -2641.215% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -11521.217% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 6098.094% |
| Acasti Pharma Inc. | -23 Million USD | -1992.88% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -14198.612% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2862.988% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -249.548% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -15349.649% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -2065.649% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -2492.854% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -184.424% |
| PepGen Inc. | -60.67 Million USD | -693.583% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1995.521% |
| United Therapeutics Corporation | -507.7 Million USD | 5.167% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -2417.343% |
| Solid Biosciences Inc. | -47.75 Million USD | -908.308% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -55748.874% |
| Immuneering Corporation | -54.94 Million USD | -776.305% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -11353.988% |
| Silo Pharma, Inc. | -3.52 Million USD | -13561.32% |
| Belite Bio, Inc | -87.27 Million USD | -451.692% |
| XOMA Corporation | -29 Million USD | -1560.231% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -581.029% |
| Bionomics Limited | 227 Million USD | 312.091% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -314.051% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -18907.777% |
| uniQure N.V. | -102.95 Million USD | -367.666% |
| Cassava Sciences, Inc. | -121.13 Million USD | -297.46% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -11458.644% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 1275.715% |
| Forte Biosciences, Inc. | -11.96 Million USD | -3925.307% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -15460.306% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 454314.151% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -14746.346% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 5506.704% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -6392.273% |
| Altimmune, Inc. | -134.48 Million USD | -258.003% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 343.085% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -18907.777% |
| Compugen Ltd. | -12.9 Million USD | -3631.145% |
| Peak Bio, Inc. | 10.34 Million USD | 4756.283% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -170029.682% |
| Benitec Biopharma Inc. | -50.58 Million USD | -851.854% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -361.449% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 2550.837% |
| Zura Bio Limited | -99.8 Million USD | -382.403% |
| PolyPid Ltd. | 6.17 Million USD | 7903.355% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 749.578% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 2550.837% |
| Instil Bio, Inc. | 75.35 Million USD | 738.906% |
| argenx SE | -2.02 Billion USD | 76.269% |
| Immunome, Inc. | -97.02 Million USD | -396.209% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -2040.329% |
| Verona Pharma plc | -220.44 Million USD | -118.409% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -571.1% |
| Shattuck Labs, Inc. | -121.42 Million USD | -296.517% |
| CervoMed Inc. | -7.79 Million USD | -6078.32% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -159.552% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -10909.993% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -265.468% |
| Moolec Science SA | 117.61 Thousand USD | 409455.02% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -20943.35% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 3128.403% |
| AnaptysBio, Inc. | -18.15 Million USD | -2552.565% |
| Design Therapeutics, Inc. | -18.15 Million USD | -2552.711% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -584.087% |
| NeurAxis, Inc. | 145.7 Thousand USD | 330550.927% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 4386.565% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1589.773% |
| Achilles Therapeutics plc | -126.92 Million USD | -279.335% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -571.1% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -73324.58% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -2217.662% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 33119.552% |
| Nutriband Inc. | -251.65 Thousand USD | -191218.739% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -3555.508% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -6371.331% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 241.526% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 2128.511% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -7.597% |
| Palisade Bio, Inc. | -12.06 Million USD | -3891.271% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -243.143% |
| Beam Therapeutics Inc. | -262.72 Million USD | -83.261% |
| Neurogene Inc. | -131.95 Million USD | -264.872% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 2306.944% |
| AEON Biopharma, Inc. | -4.88 Million USD | -9766.127% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -27.645% |
| Sesen Bio, Inc. | -112.55 Million USD | -327.769% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -382.142% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -20407.217% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -1133.708% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -478.117% |
| Athira Pharma, Inc. | -88.99 Million USD | -440.98% |
| Vaccinex, Inc. | -1.28 Million USD | -37280.978% |
| HCW Biologics Inc. | 2.85 Million USD | 16954.099% |
| XOMA Corporation | -29 Million USD | -1560.231% |
| Nektar Therapeutics | 210.24 Million USD | 329.008% |
| Arvinas, Inc. | -313.8 Million USD | -53.431% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 29767.26% |
| Merus N.V. | -192.88 Million USD | -149.615% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 902.646% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -6839.565% |
| Rezolute, Inc. | -68.16 Million USD | -606.295% |
| Clene Inc. | 3.34 Million USD | 14515.18% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -3551.073% |
| BeyondSpring Inc. | -13.75 Million USD | -3400.305% |
| Synlogic, Inc. | -6.68 Million USD | -7102.199% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 42557.407% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -5594.465% |
| Peak Bio, Inc. | 10.34 Million USD | 4756.283% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -484.163% |
| Krystal Biotech, Inc. | -350.23 Million USD | -37.47% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 487.889% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -184.898% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -15150.08% |
| MannKind Corporation | 143.89 Million USD | 434.587% |
| Ikena Oncology, Inc. | -109.15 Million USD | -341.082% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -6259.358% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -1354.583% |
| Gossamer Bio, Inc. | 180.35 Million USD | 366.955% |
| CohBar, Inc. | -5.93 Million USD | -8018.173% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1518.485% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 10644.612% |
| Legend Biotech Corporation | -949.39 Million USD | 49.287% |
| Mural Oncology plc | -255.84 Million USD | -88.188% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1594.543% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -10120.836% |
| Disc Medicine, Inc. | -358.28 Million USD | -34.383% |
| Champions Oncology, Inc. | 4.81 Million USD | 10105.549% |
| REGENXBIO Inc. | 54.76 Million USD | 979.103% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -178945.916% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -218.802% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -5242.506% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -496.739% |
| Vaxart, Inc. | -8.24 Million USD | -5742.337% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -859.48% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -278.614% |
| Cellectis S.A. | -43.85 Million USD | -997.861% |
| Longeveron Inc. | -2.9 Million USD | -16456.637% |
| Repare Therapeutics Inc. | -107.85 Million USD | -346.39% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 149.719% |
| Inozyme Pharma, Inc. | 12 Million USD | 4110.888% |
| Revolution Medicines, Inc. | -608.2 Million USD | 20.838% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -39043.659% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -81.605% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -220.824% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2977.056% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -64963.108% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 94.966% |
| Denali Therapeutics Inc. | -74.86 Million USD | -543.114% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -3915.002% |
| Veru Inc. | 4.77 Million USD | 10172.597% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -4181.229% |
| Cingulate Inc. | 3.08 Million USD | 15718.44% |
| Passage Bio, Inc. | 4.58 Million USD | 10600.916% |
| Context Therapeutics Inc. | -14.44 Million USD | -3231.991% |
| Exicure, Inc. | 5.84 Million USD | 8331.612% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -108.992% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -1116.748% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 3168.428% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -718.529% |
| Nuvalent, Inc. | -335.38 Million USD | -43.556% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 27860.804% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -546.421% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -5315.827% |
| OmniAb, Inc. | 9.2 Million USD | 5331.631% |
| Anew Medical, Inc. | 1.43 Million USD | 33711.083% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 3039.044% |
| Lipocine Inc. | -4.75 Million USD | -10026.358% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -338.383% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 3261.099% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -850.407% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 2034.224% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -7063.621% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -631.413% |
| Ocugen, Inc. | -32.52 Million USD | -1380.48% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -462.626% |
| Q32 Bio Inc. | -37.94 Million USD | -1168.755% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -76566.72% |
| Alumis Inc. Common Stock | -13.52 Million USD | -3458.777% |
| Equillium, Inc. | -22.39 Million USD | -2050.174% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1783.084% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -1375.681% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -194106.482% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 459.191% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 15155.253% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 146691.625% |
| Dominari Holdings Inc. | 195 Thousand USD | 247006.154% |
| Edesa Biotech, Inc. | -5.26 Million USD | -9041.356% |
| vTv Therapeutics Inc. | -8.91 Million USD | -5299.428% |
| Bio-Techne Corporation | 267.74 Million USD | 279.822% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2870.368% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -307.698% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -5629.704% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -3705.762% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -96.422% |
| Nkarta, Inc. | 57.29 Million USD | 940.271% |
| BioCardia, Inc. | 212 Thousand USD | 227207.075% |
| Iterum Therapeutics plc | 13.43 Million USD | 3682.877% |